Advertisement
UK markets closed

  • NIKKEI 225

    40,913.65
    +332.89 (+0.82%)
     

  • HANG SENG

    18,028.28
    +49.71 (+0.28%)
     

  • CRUDE OIL

    84.06
    +0.18 (+0.21%)
     

  • GOLD FUTURES

    2,369.40
    0.00 (0.00%)
     

  • DOW

    39,308.00
    -23.90 (-0.06%)
     

  • Bitcoin GBP

    45,612.11
    -1,209.94 (-2.58%)
     

  • CMC Crypto 200

    1,213.62
    -47.56 (-3.77%)
     

  • NASDAQ Composite

    18,188.30
    +159.54 (+0.88%)
     

  • UK FTSE All Share

    4,497.97
    +34.88 (+0.78%)
     
Money:

What Labour needs to do for pensions and work if it wins election

The next government should hit the ground running — here is what should be on the to-do list in the first 100 days

Inspire Medical Systems, Inc. to Report Second Quarter 2024 Financial Results on August 6, 2024

Inspire Medical Systems
·1-min read
Inspire Medical Systems
Inspire Medical Systems

MINNEAPOLIS, July 02, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the second quarter 2024 after the close of trading on Tuesday, August 6. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.

A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspire's Q2 2024 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast.

If you plan to ask a question, please use the following link: Inspire's Q2 2024 earnings call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call.

ADVERTISEMENT

Following the call, a replay will be available on the Company's Investor Relations website approximately two hours after the event and archived on the site for two weeks.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443